Post-approval studies (Phase 4)Study completedNCT01316718
What this trial is testing
Mesalazine for the Treatment of Diarrhoea-predominant Irritable Bowel Syndrome (IBS-D)
Who this might be right for
Irritable Bowel Syndrome With Diarrhoea
University of Nottingham 108